Philip Ashton-Rickardt is CHIEF SCIENTIFIC OFFICER of Sigilon Therapeutics Inc.
Person profile
Roles
Sigilon Therapeutics
CHIEF SCIENTIFIC OFFICER
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.75 | 8,845 | 6.63 k | 0 |
28 Feb 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.09 | 115,000 | 125.35 k | 115,000 |